|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| CASH FLOW FROM OPERATING ACTIVITIES: | |||||
| Net income (loss) | |||||
| Depreciation | |||||
| Depreciation and amortization | |||||
| Non-cash, in-kind interest settled | |||||
| Compensation paid through issuance of common stock | |||||
| Goodwill and intangible assets impairment | |||||
| Gain on settlement of liability | |||||
| Gain on disposition of property | |||||
| Deferred compensation in connection with Series A preferred shares | |||||
| Goodwill impairment | |||||
| Inventory adjustment | |||||
| Loss on debt extinguishment | |||||
| Loss on settlement of liability | |||||
| Adjustments to reconcile net loss to cash (used in) operating activities: | |||||
| Accounts receivable | |||||
| Prepaid expense and other | |||||
| Inventory | |||||
| Inventory deposits | |||||
| Lease deposits and other | |||||
| Accounts payable | |||||
| Accrued expenses | |||||
| Accrued interest | |||||
| Deferred revenue | |||||
| Other assets and liabilities | |||||
| Right-of-use lease liabilities | |||||
| Net Cash (Used in) Operating Activities | |||||
| CASH FLOW FROM INVESTING ACTIVITIES: | |||||
| Purchase of Champion Entities | |||||
| Purchases of property and equipment | |||||
| Net Cash Provided by Investing Activities | |||||
| CASH FLOW FROM FINANCING ACTIVITIES: | |||||
| Offering costs paid | |||||
| Proceeds from line of credit | |||||
| Payments on loans - officer - related party | |||||
| Proceeds from loans - director - related party | |||||
| Proceeds from working capital loans, net | |||||
| Repayments of working capital loans, net | |||||
| Origination fees | |||||
| Origination fees paid | |||||
| Payments on line of credit | |||||
| Proceeds from issuance of Series D preferred stock | |||||
| Proceeds from issuance of Common stock | |||||
| Proceeds from sale of warrant inducement, net of offering costs | |||||
| Proceeds from sale of common stock and prefunded warrants, net of offering costs | |||||
| Proceeds from exercise of prefunded warrants | |||||
| Net Cash Provided by Financing Activities | |||||
| CHANGE IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH | |||||
| CASH, CASH EQUIVALENTS, AND RESTRICTED CASH AT BEGINNING OF YEAR | |||||
| CASH AND CASH EQUIVALENTS AT END OF YEAR | |||||
| RESTRICTED CASH AT END OF YEAR | |||||
| TOTAL CASH, CASH EQUIVALENTS, AND RESTRICTED CASH AT END OF YEAR | |||||
| Cash paid for: | |||||
| Interest | |||||
| Issuance of Series A preferred stock pursuant to employment agreement – related party | |||||
| Modification of conversion terms of Series A preferred stock previously issued pursuant to employment agreements – related parties | |||||
| Non-cash operating activities: | |||||
| Prepaid expenses paid for with issuance of Company stock | |||||
| Liabilities settled with issuance of Company stock | |||||
| Non-cash investing activities: | |||||
| Investments purchased with Company stock | |||||
| Non-cash financing activities: | |||||
| Debt converted to Company stock | |||||
Loading...